Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer

BACKGROUND: The addition of oxaliplatin to adjuvant 5-fluorouracil (5-FU) improves survival of patients with stage III colon cancer in randomized clinical trials (RCTs). However, RCT participants are younger, healthier, and less racially diverse than the general cancer population. Thus, the benefit...

詳細記述

保存先:
書誌詳細
主要な著者: Sanoff, Hanna K., Carpenter, William R., Martin, Christopher F., Sargent, Daniel J., Meyerhardt, Jeffrey A., Stürmer, Til, Fine, Jason P., Weeks, Jane, Niland, Joyce, Kahn, Katherine L., Schymura, Maria J., Schrag, Deborah
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2012
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3274510/
https://ncbi.nlm.nih.gov/pubmed/22266473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djr524
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料